Galventa AG

www.galventa.com

We are on a mission to help you to synchronise your circadian rhythm to improve sleep and waking-up through the development of innovative and clinically tested galenic platform technologies. Our first galenic formulation is based on our own life story: We, the founders, find it difficult to get up in the morning and are so-called night owls, who are more efficient in the evening or even at night. In countless situations however, we are required to perform well in the early hours of the day. Accordingly, our biological clock often does not match with our lifestyles. With our first dietary supplement B・SYNC ON we not only succeed in waking up with ease, but we also adjust our inner clock in such a way that it fits to our lifestyles. We turn a "night owl" into an "early bird". Galventa has filed for one nutraceutical patent in early 2021. The patent covers technical, process-related and application-based aspects of our invention. It also contains the study results from our clinical trial. The extended search report came back very promising and we believe the patent will be granted in due time.

Read more

Reach decision makers at Galventa AG

Lusha Magic

Free credit every month!

We are on a mission to help you to synchronise your circadian rhythm to improve sleep and waking-up through the development of innovative and clinically tested galenic platform technologies. Our first galenic formulation is based on our own life story: We, the founders, find it difficult to get up in the morning and are so-called night owls, who are more efficient in the evening or even at night. In countless situations however, we are required to perform well in the early hours of the day. Accordingly, our biological clock often does not match with our lifestyles. With our first dietary supplement B・SYNC ON we not only succeed in waking up with ease, but we also adjust our inner clock in such a way that it fits to our lifestyles. We turn a "night owl" into an "early bird". Galventa has filed for one nutraceutical patent in early 2021. The patent covers technical, process-related and application-based aspects of our invention. It also contains the study results from our clinical trial. The extended search report came back very promising and we believe the patent will be granted in due time.

Read more
icon

Country

icon

City (Headquarters)

Sankt Gallen

icon

Employees

1-10

icon

Founded

2018

icon

Social

  • icon
  • icon

Employees statistics

View all employees

Potential Decision Makers

  • Co - Founder and Chief Technical Officer ( Chief Technology Officer )

    Email ****** @****.com
    Phone (***) ****-****
  • Chief Marketing Officer

    Email ****** @****.com
    Phone (***) ****-****

Technologies

(1)

Reach decision makers at Galventa AG

Free credits every month!

My account

Sign up now to uncover all the contact details